首页> 外文期刊>The pharmaceutical journal >Investigating treatment strategies for MERS-CoV
【24h】

Investigating treatment strategies for MERS-CoV

机译:研究MERS-CoV的治疗策略

获取原文
获取原文并翻译 | 示例
           

摘要

On 13 June 2012, a palienl presented at Dr Soliman Fakeeh Hospital in Jeddah, Saudi Arabia, with what seemed like pneumonia and renal failure. The patient died 11 days later. Virologist Ali Mohamed Zaki, who worked in the hospital's diagnostic laboratory, suspected that sputum samples obtained from the patient contained a virus. But it was not until several months later, with a spate of patients across the Middle East reporting similar respiratory symptoms, that he confirmed his hunch. The ill ness was caused by a novel coronavirus, dubbed Middle East respiratory syndrome coronavirus (MERS-CoV). Coronaviruses arc a species that often infect humans and are one of the causes of the common cold. "The reason there is no specific treatment is that coronavirus es used to be so mild that nobody really cared," says Jasper Chan, a microbiologist at the University of Hong Kong.
机译:2012年6月13日,在沙特阿拉伯吉达的Soliman Fakeeh医院就诊的患者出现肺炎和肾功能衰竭。患者在11天后死亡。在医院诊断实验室工作的病毒学家Ali Mohamed Zaki怀疑从患者那里获得的痰液样本中含有病毒。但是直到几个月后,中东地区的一大批患者都报告了类似的呼吸道症状,他才证实了自己的直觉。这种疾病是由一种新型的冠状病毒引起的,该病毒被称为中东呼吸综合征冠状病毒(MERS-CoV)。冠状病毒是经常感染人类的​​物种,并且是普通感冒的原因之一。香港大学的微生物学家Jasper Chan说:“没有特异性治疗的原因是,冠状病毒过去是如此温和,以至于没人真正关心。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号